CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.

CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.

We have demonstrated earlier that CTIP2 is highly expressed in mouse skin during embryogenesis and in adulthood. CTIP2 mutant mice die at birth with epidermal differentiation defects and a compromised epidermal permeability barrier suggesting its role in skin development and/or homeostasis. CTIP2 ha...

Full description

Bibliographic Details
Main Authors:	Gitali Ganguli-Indra, Christine Wasylyk, Xiaobo Liang, Regine Millon, Mark Leid, Bohdan Wasylyk, Joseph Abecassis, Arup K Indra
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2009-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC2671404?pdf=render

Similar Items

Correction: CTIP2 Expression in Human Head and Neck Squamous Cell Carcinoma Is Linked to Poorly Differentiated Tumor Status.
by: Gitali Ganguli-Indra, et al.
Published: (2009-01-01)

Delayed cutaneous wound healing and aberrant expression of hair follicle stem cell markers in mice selectively lacking Ctip2 in epidermis.
by: Xiaobo Liang, et al.
Published: (2012-01-01)

Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.
by: Zhixing Wang, et al.
Published: (2012-01-01)

Correction: CTIP2 Expression in Human Head and Neck Squamous Cell Carcinoma Is Linked to Poorly Differentiated Tumor Status
Published: (2009-01-01)

Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells.
by: Gunjan Guha, et al.
Published: (2015-01-01)

Study of a Novel Gene Overexpressed in Head & Neck Tumors
by: A Seghatoleslam, et al.
Published: (2005-10-01)

The oncogenic MicroRNA Hsa-miR-155-5p targets the transcription factor ELK3 and links it to the hypoxia response.
by: E Douglas Robertson, et al.
Published: (2014-01-01)

A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer
by: Jana Mourtada, et al.
Published: (2023-10-01)

Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on <i>EREG</i>-Driven Oncogenic Addiction
by: Sylvie Job, et al.
Published: (2019-06-01)

Selective Ablation of BCL11A in Epidermal Keratinocytes Alters Skin Homeostasis and Accelerates Excisional Wound Healing In Vivo
by: Nilika Bhattacharya, et al.
Published: (2022-07-01)

Photoprotective Properties of Isothiocyanate and Nitrile Glucosinolate Derivatives From Meadowfoam (Limnanthes alba) Against UVB Irradiation in Human Skin Equivalent
by: Evan L. Carpenter, et al.
Published: (2018-05-01)

Bioengineered Efficacy Models of Skin Disease: Advances in the Last 10 Years
by: Diana Nicole Stanton, et al.
Published: (2022-01-01)

Epigenetic regulation of p16Ink4a and Arf by JDP2 in cellular senescence
by: Nakade Koji, et al.
Published: (2010-05-01)

TTLL12 has a potential oncogenic activity, suppression of ligation of nitrotyrosine to the C-terminus of detyrosinated α-tubulin, that can be overcome by molecules identified by screening a compound library.
by: Amit Deshpande, et al.
Published: (2024-01-01)

XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice.
by: Kostyantyn Semenchenko, et al.
Published: (2016-01-01)

The Multifaceted Role of Human Dickkopf-3 (DKK-3) in Development, Immune Modulation and Cancer
by: Jana Mourtada, et al.
Published: (2023-12-01)

Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas
by: Sharmeen Chagani, et al.
Published: (2017-11-01)

Elk3 deficiency causes transient impairment in post-natal retinal vascular development and formation of tortuous arteries in adult murine retinae.
by: Christine Weinl, et al.
Published: (2014-01-01)

Curcumin: Pharmacological actions and its role in head and neck squamous cell carcinoma - A review
by: Abhijeet Alok, et al.
Published: (2017-01-01)

Head and Neck Squamous Cell Carcinoma in Western Uganda: Disease of Uncertainty and Poor Prognosis
by: Jamilah Nabukenya MMed, et al.
Published: (2018-03-01)

Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma
by: Mohsen Ahmadi, et al.
Published: (2021-09-01)

An easy method for preparation of Cre-loxP regulated fluorescent adenoviral expression vectors and its application for direct reprogramming into hepatocytes
by: Chitose Kurihara, et al.
Published: (2016-12-01)

FTH1 indicates poor prognosis and promotes metastasis in head and neck squamous cell carcinoma
by: Qingyun Liao, et al.
Published: (2023-11-01)

DCBLD1 Overexpression Is Associated With a Poor Prognosis in Head and Neck Squamous Cell Carcinoma
by: Ling-ling Fu, et al.
Published: (2022-07-01)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
by: Wen Gao, et al.
Published: (2022-06-01)

Tubulin tyrosine ligase like 12, a TTLL family member with SET- and TTL-like domains and roles in histone and tubulin modifications and mitosis.
by: Jan Brants, et al.
Published: (2012-01-01)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
by: Stefano Cavalieri, et al.
Published: (2021-12-01)

PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer.
by: Wigfield, S, et al.
Published: (2008)

Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma
by: Kun Cui, et al.
Published: (2022-09-01)

Corrigendum: DCBLD1 Overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma
by: Ling-ling Fu, et al.
Published: (2022-11-01)

CtIP Mutations Cause Seckel and Jawad Syndromes.
by: Per Qvist, et al.
Published: (2011-10-01)

Immunotherapy in Head and Neck Squamous Cell Cancer
by: Nerina Denaro, et al.
Published: (2018-12-01)

Exosomes in Head and Neck Squamous Cell Carcinoma
by: Cheng Xiao, et al.
Published: (2019-09-01)

Overexpression of NRP1 is Associated with Poor Prognosis via Accelerating Immunosuppression in Head and Neck Squamous Cell Carcinoma
by: Yang X, et al.
Published: (2023-07-01)

Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation
by: Kiyoshi Misawa, et al.
Published: (2020-01-01)

Neck management in metastatic cutaneous squamous cell carcinoma of the head and neck
by: Ning Xu, et al.
Published: (2024-02-01)

BRCA1 and CtIP are required for processing uncapped telomeres
by: Tarsounas, M
Published: (2010)

Satb2 and Ctip2 genes in the control of neocortical connectivity
by: Romero, C, et al.
Published: (2008)

Structural basis for the coiled-coil architecture of human CtIP
by: C. R. Morton, et al.
Published: (2021-06-01)

Immune Cell Deconvolution Reveals Possible Association of γδ T Cells with Poor Survival in Head and Neck Squamous Cell Carcinoma
by: Anuraag S. Parikh, et al.
Published: (2023-10-01)